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Infection of cells in G1 phase with herpes simplex virus (HSV) prevents their progression into S phase (de Bruyn Kops, A.,
and Knipe, D. M., 1988, Cell 55, 857–868). We have examined G1-phase events in infected cells to determine whether this
effect was the result of inhibition of G1 phase progression or of entry into S phase. We observed that HSV infection
decreased pRb phosphorylation and induced a new phosphorylated form of pRb. Furthermore, HSV infection prevented the
normal G1 increases in cyclin D1 and D3 protein levels, and blocked the normal G1 appearance of new electrophoretic forms
of cdk2 and cdk4. Thus, HSV infection inhibits several events that normally occur in the cell cycle during G1 phase, arguing
that the HSV-induced block in the cell cycle occurs in early to mid-G1 phase. © 2000 Academic Press
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Viruses modify their host cells in many ways to opti-
mize their own replication. In return, the host cell modi-
fies its metabolism in response to stresses such as viral
infection in an attempt to protect itself. As part of their
manipulation of host cells, viruses often modify the host
cell-cycle regulatory machinery to facilitate their replica-
tion. For example, DNA tumor viruses such as simian
virus 40 (DeCaprio et al., 1988), adenovirus (Whyte et al.,
1988), and papilloma virus (Dyson et al., 1989) encode
proteins that bind to and eliminate the growth-inhibitory
function of the cellular pRb protein. This stimulates cells
to move into S phase so that S-phase functions needed
for genomic viral DNA replication of these viruses are
available (Knipe, 1996).
In contrast, herpes simplex virus replicates equally
well in all phases of the cell cycle (Cohen et al., 1971; Cai
and Schaffer, 1991; Yeh and Knipe, unpublished results).
Furthermore, herpes simplex viruses encode seven pro-
teins essential for viral DNA synthesis, including a DNA
polymerase as well as functional homologs of several
S-phase functions, including ribonucleotide reductase
and thymidine kinase, suggesting that cellular S-phase
factors are not required for an efficient infection. Indeed,
we have shown that HSV infection of cells in the G1
phase prevents those cells from entering S phase (de
Bruyn Kops and Knipe, 1988). Recently, several groups
have reported various interactions of HSV with the cell
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326cycle. First, one study concluded that HSV-2 infection
leads to increased phosphorylation of pRb, which would
be consistent with cells moving into S phase, transient
activation of cdk2 activity, but lack of cell-cycle progres-
sion (Hossain et al., 1997). Second, it has been reported
that HSV-1 ICP0 protein binds to and stabilizes cyclin D3
(Kawaguchi et al., 1997). Third, it has been reported that
cyclin-dependent kinases are required for HSV replica-
tion and transcription (Schang et al., 1998), possibly in-
dicating a need for cell-cycle progression during viral
infection. In contrast, a fourth paper reported that HSV
induces the accumulation of a hypophosphorylated form
of pRb and the accumulation of E2F-pRb DNA binding
complexes (Olgiate et al., 1999), consistent with our ob-
servation that HSV infection inhibits cell-cycle progres-
sion. Thus, the effects of HSV on the cell cycle are not
well defined.
Progression of the cell cycle from G0 to S phase is
regulated by a series of events, including the sequential
assembly, activation, and subsequent inactivation of a
series of cyclin-dependent kinase (cdk) complexes
(Pines, 1993). The expression of D-type cyclins is stimu-
lated by growth factors and mitogens (Matsushime et al.,
1992; Bates et al., 1994; Myerson and Harlow, 1994). The
-type cyclins associate with and activate the cyclin-
ependent kinases cdk2, cdk4, cdk5, and cdk6 (Matsu-
hime et al., 1992; Xiong et al., 1992; Myerson and Har-
ow, 1994). Of these enzymes, cdk4 and cdk6 appear to
e the most abundant D-type cyclin partners. Cyclin E
ppears to be the major cdk2 regulatory subunit in vivo
Dulic et al., 1992; Koff et al., 1992), and this complex is
lso necessary for completion of the G1/S-phase transi-
ion (Hatakeyama et al., 1994).
Some of the major targets of the cdk–cyclin complexes
re the retinoblastoma family of proteins, pRb, p107, and
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Phosphorylation of pRb in mid-G1 is required for cells to
exit G1 into S phase (Sherr, 1993). pRb is found in a
hypophosphorylated form in quiescent cells and early G1
and then becomes phosphorylated on several cdk con-
sensus sites during mid- to late-G1. The hypophosphor-
ylated form of pRb binds to and inhibits several cellular
proteins that are involved in activating the transcription
of genes whose products are required for S-phase pro-
gression (reviewed by Nevins, 1994; Weinberg, 1995). G1
arrest is known to be associated with accumulation of
unphosphorylated pRb (Buchkovich et al., 1989; De-
Caprio et al., 1989).
To clarify the effects of HSV on the host-cell cycle and
to determine whether HSV infection blocks the cell cycle
immediately before S phase or within the G1 phase, we
examined the effects of HSV infection on the host-cell
proteins involved in the G1 progression and G1/S tran-
sition. Our results demonstrate that HSV infection leads
to an inhibition of G1 phase-specific events, consistent
with a block in early- to mid-G1 phase of the cell cycle.
RESULTS
HSV infection causes a change in the electrophoretic
mobility of the cellular protein pRb
Previously, we had shown that HSV infection blocks
cell-cycle progression into S phase (de Bruyn Kops and
Knipe, 1988). To determine whether this was the result of
cell-cycle arrest in the G1 phase and to explore the
molecular mechanisms for this effect, we examined the
effects of HSV infection on the host-cell proteins involved
in G1 progression and the G1/S transition, including pRb,
cyclins, and cdks.
To examine the effects of HSV infection on pRb, we
infected CV-1 cells with HSV-1 or mock-infected the cul-
FIG. 1. Alteration in the electrophoretic mobility of the retinoblastoma
protein (pRb) during HSV-1 infection. CV-1 cells were infected with
HSV-1 at a multiplicity of infection (m.o.i.) of 10 (HSV) or mock-infected
(mock). Total cell extracts were prepared at 5.5 h postinfection (hpi).
Following immunoprecipitation with mouse antihuman Rb monoclonal
antibody, each sample was resolved in an SDS–polyacrylamide gel,
transferred onto a nitrocellulose membrane, and analyzed by immuno-
blotting using the same monoclonal antibody. The immunoblot image is
shown. The species of pRb in the mock-infected cell extracts arel
labeled as a–d. The new species of pRb appearing in HSV-infected cell
extracts is labeled as b9.tures, prepared total cell extracts, and examined pRb by
immunoprecipitation and immunoblotting (Fig. 1). Four
distinct species of pRb, ranging in size from 105 to 120
kDa (bands a, b, c, and d), were apparent in the mock-
infected cell extracts (Fig. 1, lane 1). On HSV infection,
there was a noticeable shift in the mobility of pRb toward
the higher mobility species and the appearance of a new
band, labeled b9, the letter migrating slightly faster than
the b band (Fig. 1, lane 2). Although the relative intensity
of each pRb species varied slightly from one experiment
to the other, the overall downward shift of the pRb spe-
cies and the appearance of the new b9 species were
observed consistently on HSV infection. Although the
total amount of pRb recovered from infected and mock-
infected cultures varied somewhat (Fig. 1), there was no
consistent effect of HSV infection on pRb levels (Liu and
Knipe, unpublished results).
The phosphorylation status of pRb changes on HSV
infection
There were several potential explanations for the ob-
served mobility shifts of pRb, including phosphorylation,
glycosylation, and acetylation. Phosphorylation plays an
important role in regulating the function of pRb (DeCaprio
et al., 1989; Lin, 1991; Mittnacht and Weinberg, 1991;
Alberts et al., 1993). Therefore, we determined whether
the mobility change of pRb was the result of an alteration
in the phosphorylation status of pRb. After phosphatase
treatment, pRb from both mock-infected and HSV-in-
fected cells comigrated as a single band (Fig. 2, lanes 1
and 3). The phosphatase-treated pRb species comi-
grated with the fastest migrating pRb species from HSV-
infected cells. These results support the idea that the
HSV-induced mobility changes of pRb, including the new
b9 band, were the result of changes in the phosphoryla-
tion of this protein.
To confirm the alteration in the phosphorylation status
32
FIG. 2. Phosphatase treatment of pRb, which was prepared by
immunoprecipitation with mouse anti-pRb monoclonal antibody from
mock-infected or HSV-1-infected CV-1 cells. Prior to electrophoretic
separation in SDS gels and Western blotting for pRb, each immuno-
precipitate was divided into two aliquots and treated with bacterio-
phage lambda protein phosphatase or left untreated. The immunoblot
image is shown.of pRb, we performed phosphopeptide analysis of P-
abeled pRb immunoprecipitated from infected and
nel B i
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328 SONG ET AL.mock-infected cells. Representative autoradiographic
maps are shown (Fig. 3), and the detected phosphopep-
tide spots have been designated numerically (Fig. 3D).
Interestingly, the intensity of some spots changed on
HSV infection (Figs. 3A and 3C). Spots 1 and 2 were
FIG. 3. Two-dimensional phosphopeptide analysis of pRb. Mock-infe
immunoprecipitated with mouse anti-pRb monoclonal antibody, resol
autoradiogram as a guide. Following trypsin digestion, the peptides we
plates were exposed to X-ray films with intensifying screens. Each sam
tides from mock-infected (A) and HSV-infected (C) cells are shown. Pa
(1:1). Panel D is a composite map of phosphopeptide analysis of pRb.absent in pRb from mock-infected cells (Fig. 3A) but
present in large quantity in pRb from HSV-infected cells(Fig. 3C). Spots 4 and 12, clearly observed in mock-
infected cells, disappeared on HSV infection. The inten-
sity of spot 6 increased slightly on viral infection, and that
of spots 7, 8, 9, 10, 11, and 13 decreased slightly on viral
infection. In total, these results show that phosphoryla-
HSV-1-infected CV-1 cells were labeled with 32P-phosphate. pRb was
SDS–PAGE, and the pRb band was excised from the gel using the
rated on thin-layer plates by electrophoresis and chromatography. The
ntained 500 Cerenkov cpm. Autoradiographic images of phosphopep-
s from the mixture of mock-infected sample and HSV-infected sample
rigin is indicated with an arrow in each panel.cted or
ved by
re sepa
ple cotion of pRb changes on HSV infection and indicate that
this alteration in the phosphorylation is responsible for
t
r
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ing viral infection.
HSV effects on pRb in growing and resting cells
To further examine the effects of HSV infection on pRb,
we performed experiments under two different condi-
tions: (1) infection of actively growing cells and (2) infec-
tion of growth-arrested cells. In actively growing cells,
HSV infection shifted the majority of pRb species to the
higher mobility species by 4–6 h postinfection (hpi), while
the electrophoretic profile of pRb species remained the
same in mock-infected cells during the time course of
this experiment (Fig. 4). In contrast, in serum-starved
cells, the major band was the a band (Fig. 5, lane 1).
Addition of medium containing 10% serum allowed the
cells to reenter the cell cycle and to accumulate the
slower-migrating, more highly phosphorylated pRb spe-
cies (Fig. 5, even-numbered lanes). In contrast, HSV
infection prevented the serum-induced shift of pRb to the
c and d bands but induced the formation of the b9
species (Fig. 5, odd-numbered lanes). Furthermore, HSV
infection induced the b9 form even in cells maintained in
he growth-arrested state (Liu and Knipe, unpublished
esults).
FIG. 4. Alteration of pRb mobility during HSV-1 infection of actively
growing cells. CV-1 cells were maintained in DMEM supplemented
with 10% fetal calf serum for 16 h prior to infection with HSV-1 (m.o.i. of
10) or mock-infection. Both mock-infected (M) and HSV-1-infected (V)
cells were then overlaid with fresh DMEM supplemented with 10% fetal
calf serum until the time of harvest indicated at the top of the panel. The
total cell lysates were analyzed by immunoblotting analysis using
mouse antihuman Rb monoclonal antibody. The immunoblot image is
shown. The different pRb species are indicated on the right-hand side
of the panel.
FIG. 5. Alteration of pRb mobility during HSV-1 infection of growth-
containing 1% calf serum for 24 h. They were then infected with HSV-1 (V) or
the immunoblotting analysis of pRb at the indicated times as described in thThe shift of pRb to the faster-migrating species was
observed by 4 hpi. (Fig. 4, lane 4), suggesting the pos-
sible involvement of a virion component, a viral immedi-
ate-early, or an early protein in this process. Consistent
with these kinetics, the pRb mobility shift was also ob-
served in infections maintained in medium containing
phosphonoacetate to inhibit viral DNA synthesis (Yeh
and Knipe, unpublished results). This mobility shift con-
tinued during the course of viral infection and became
more prominent at late times postinfection (Figs. 4 and
5). At very late times postinfection (24 hpi), the fastest-
migrating species were the major species and the slow-
migrating species were not detectable (Liu and Knipe,
unpublished results).
To determine if the effect was specific for HSV-1, we
examined cells infected with HSV-2 (Fig. 6). In actively
growing cells, HSV-2 infection shifted pRb to the faster-
migrating species by 6 hpi, while the slower-
migrating species were the major species in mock-
infected cells (Fig. 6, lanes 1 to 3). In growth-arrested
cells, the effect of viral infection on the electrophoretic
d cells. CV-1 cells were growth-arrested by culturing in 199 medium
FIG. 6. Alteration of pRb mobility during HSV-2 infection. CV-1 cells
were infected with HSV-2 (V) or mock-infected (M) and processed for
immunoblotting analysis of pRb. Prior to viral infection, one batch of
cells was grown in DME medium supplemented with 10% fetal calf
serum (cycling) and the other batch of cells was maintained in 199
medium containing 1% serum for 24 h to induce growth arrest by serum
starvation (G0-arrested). At 1 hpi, all cells were overlaid with DME–10%
serum. Cell extracts from cycling cells (lanes 1 to 3) and from G0-
arrested cells (lanes 4 to 6) were prepared at 0 and 6 h postinfection.
The immunoblot image is shown.arreste
mock-infected (M), overlaid with DME–10% serum and processed for
e legend of Fig. 5.
330 SONG ET AL.mobility of pRb was more dramatic than in actively grow-
ing cells (Fig. 6, lanes 4 to 6). pRb shifted to the slower-
migrating forms when the growth-arrested cells were
grown for 6 h in medium supplemented with 10% fetal
bovine serum, but HSV-2 infection actively repressed the
conversion and the majority of pRb remained as fast-
migrating species (Fig. 6, lanes 4 to 6). Thus, both HSV-1
and HSV-2 caused a change in the electrophoretic mo-
bility of pRb toward the fast-migrating forms.
G1 cyclins and cyclin-dependent kinases (cdks) in
HSV-infected cells
Phosphorylation of pRb in the G1 phase of the cell
cycle is performed by cyclin-dependent kinases acti-
vated by binding of their cyclin partners. Thus, to explore
the molecular mechanisms responsible for the altered
phosphorylation of pRb in HSV-infected cells, we exam-
ined the levels of the G1 cyclins, cyclin D1, cyclin D2,
cyclin D3, and cyclin E, and their catalytic partners, cdk2,
cdk4, cdk5, and cdk6, in HSV- and mock-infected cells.
As expected, the levels of cyclin D1 (Fig. 7A, lanes 1
and 2) and cyclin D3 (Fig. 7C, lanes 1 and 2) increased as
FIG. 7. Effect of HSV infection on D-cyclin levels. Following growth-
arrest induced by serum starvation, CV-1 cells were infected with
HSV-2 or mock-infected (M) and overlaid with DME–10% serum. Total
cell extracts were examined for cyclin D1 (A), D2 (B), or D3 (C) by
immunoblotting analysis. Lane 1: mock-infected and harvested at 0 hpi.
Lane 2: mock-infected and harvested at 6 hpi. Lanes 3 to 5: infected
with HSV-2 strain 186 at an m.o.i. of 3.3 (lane 3), 10 (lane 4), or 20 (lane
5), and harvested at 6 hpi.cells moved from G0 through G1 phase. In contrast, the
level of cyclin D2 was constant as the cells movedthrough G1 (Fig. 7B). However, the induction of cyclin D1
and cyclin D3 was blocked in HSV-2-infected cells (Figs.
7A and 7C), while the level of cyclin D2 was not signifi-
cantly affected by viral infection (Fig. 7B). The effect of
viral infection was most dramatic with cyclin D1, and
cyclin D1 was almost undetectable in HSV-infected cells
by 6 hpi, even at a multiplicity of infection (m.o.i.) of 3.3
(Fig. 7A, lane 3).
Cdk4 protein, a major catalytic partner of D-type cyc-
lins, ran as a doublet (Fig. 8). The level of the faster-
migrating form of cdk4 increased as cells moved from G0
through G1 phase (Fig. 8, lanes 4 and 5). The increase of
the faster-migrating species of cdk4 was blocked in
HSV-infected cells both in actively growing cells (Fig. 8,
lanes 1 to 3) and in growth-arrested cells (Fig. 8, lanes 4
to 6).
Two other cyclin D-dependent kinases, cdk5 (Fig. 9A)
FIG. 8. Effect of HSV infection on cdk4 level. CV-1 cells in two
different growth conditions, cycling or G0-arrested, were infected with
HSV-2 (V) or mock-infected (M). Total cell extracts were examined for
cdk4 by immunoblotting analysis and the immunoblot image is shown.
Lanes 1 to 3 are from cycling cells and lanes 4 to 6 are from G0-
arrested cells.
FIG. 9. Effect of HSV infection on cdk5 and cdk6 levels. Following
growth-arrest induced by serum starvation, CV-1 cells were infected
with HSV-2 or mock-infected (M) and overlaid with DME–10% serum.
Total cell extracts were examined for cdk5 (A) or cdk6 (B) by immuno-
blotting analysis. Three different m.o.i.’s were used for the HSV-2
infections: 3.3 (lane 3), 10 (lane 4), and 20 (lane 5).
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331HSV INFECTION BLOCKS EVENTS IN G1 PHASE OF CELL CYCLEand cdk6 (Fig. 9B), increased slightly during G1 phase.
Following viral infection, the levels of cdk5 (Fig. 9A) and
cdk6 (Fig. 9B) were not changed reproducibly. The level
of another G1 cyclin, cyclin E, remained unchanged for at
least 6 h after the release from serum starvation, and
there was no effect of HSV infection on the level of cyclin
E (Fig. 10A).
Finally, we examined cdk2, a catalytic partner of cyclin
E. As with cdk4, cdk2 ran as a doublet and the level of
the faster-migrating species of the protein increased as
cells moved from G0 through G1 phase (Fig. 10B, lanes
1 and 2). The induction of the faster-migrating species of
cdk2 was blocked in HSV-infected cells (Fig. 10B, lanes
3 to 5 versus lane 2). There is experimental evidence that
the protein with the faster migration is the active form of
cdk2 (Gu et al., 1992). Thus, HSV infection appears to
lock the normal appearance of the active form of cdk2
n G1.
In conclusion, our results suggest that the normal G1
ncreases in protein levels or electrophoretic forms of G1
yclins and cdks are inhibited by HSV infection, and this
ay inhibit the phosphorylation of the retinoblastoma
rotein (pRb) required for the G1/S transition, therefore
locking HSV-infected cells in the G1 phase.
DISCUSSION
This work was intended to extend our previous obser-
ation that HSV-1 infection in the G1 phase of the cell
ycle prevented cells from entering S phase (de Bruyn
ops and Knipe, 1988). To determine whether G1 events
ere inhibited or infection was blocking cellular entry
nto S phase, we first examined the effect of HSV infec-
FIG. 10. Effect of HSV infection on cyclin E and cdk2 levels. Following
rowth-arrest induced by serum starvation, CV-1 cells were infected
ith HSV-2 or mock-infected (M) and overlaid with DME–10% serum.
otal cell extracts were examined for cyclin E (A) or cdk2 (B) by
mmunoblotting analysis. The immunoblot image is shown. Three dif-
erent m.o.i.’s were used for the HSV-2 infections: 3.3 (lane 3), 10 (lane
), and 20 (lane 5).ion on the pRb protein. We observed that HSV infection
locked the phosphorylation of pRb in G1, a necessary
codification for progression of the cells to S phase.
hus, we observed that HSV infection reduced the
mount of hyperphosphorylated pRb observed late in G1
hase, but we also observed a new phosphorylated form
f pRb, called b9, that accumulated after viral infection.
he loss of hyperphosphorylated forms of pRb is consis-
ent with blockage of the cell cycle in G1 phase rather
han at the start of or within S phase. Further studies of
he G1 regulatory proteins showed that viral infection
revented the normal increases in levels of cyclins D1
nd D3 and the appearance of new electrophoretic forms
f cdk4 and cdk2 that occur in the G1 phase of the cell
ycle. The lack of these essential components of the cdk
oloenzyme complexes is likely to explain the reduced
hosphorylation of pRb in G1 and the cell-cycle block.
imilar effects of HSV infection on G1 cyclins and cdks
ave been observed by Ehmann et al. (2000). We con-
lude that HSV infection blocks the cell cycle in early- to
id-G1 phase. Nevertheless, HSV may induce G1- or
-phase functions by mechanisms other than progres-
ion of the cell cycle.
Although we have not yet directly measured the kinase
ctivity levels to show that these correlate with protein
evels, we have observed that the amount of the higher
lectrophoretic mobility form of cdk2 observed in G1-
tage cells and associated with enzymatic activity (Gu et
l., 1992) is decreased in HSV-infected cells. Further-
ore, Ehmann et al. (2000) have observed that cdk2
ctivity levels are reduced in HSV-infected human U20S,
33, and human embryonic lung cells. This supports the
dea that HSV reduces the level of functional cyclin–cdk
omplexes in infected cells, contributing to the block of
he cell cycle in the G1 stage.
ultiple interactions of HSV with the cell-cycle
egulatory machinery
Previous studies had suggested that HSV-2 increased
he phosphorylation of pRb (Hossain et al., 1997), while
SV-1 decreased the phosphorylation of pRb (Olgiate et
l., 1999). In our studies, we observed equivalent effects
f HSV-1 and HSV-2 on the G1/S transition and pRb
hosphorylation, so the explanation for the observed
ifferences is not likely to be type-specific differences.
ur resolution of multiple pRb species and a new elec-
rophoretic form in HSV-infected cells may explain the
aradox. Hossain et al. (1997) infected serum-starved
V-1 cells and observed a decrease in electrophoretic
obility of pRb in infected cells. Their work did not
esolve the multiple pRb species; thus, it seems likely
hat the decreased mobility of pRb observed in that study
as due to the new b9 species that we observed in
SV-infected cells and not the hyperphosphorylated
orm of pRb formed in late-G1 phase. Our results are
onsistent with those of Olgiate et al. (1999), so the
apparent differences may be reconciled.
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332 SONG ET AL.Similarly, it has been concluded that HSV ICP0 stabi-
lizes the cell-cycle regulator cyclin D3 (Kawaguchi et al.,
997; Van Sant et al., 1999), which appears to differ from
our results, showing that HSV infection decreases cyclin
D3 levels. In fact, the previous work also observed that
wild-type HSV-1 decreased cyclin D3 levels, but ICP0
mutant viruses showed more drastically reduced levels
of cyclin D3. Hence, they concluded that ICP0 stabilizes
cyclin D3. While ICP0 may indeed exert an effect on the
stability of cyclin D3, the total effect of HSV infection is to
decrease its level in the host cell.
Schang et al. (1998) have reported that cdk inhibitors
block HSV productive infection, and they have concluded
that one or more cdks active from late G1 onward are
required for HSV transcription and replication. There are
many possible explanations that might reconcile these
observations with a G1-phase block. First, the essential
cdk might not be a G1-phase function or might not be
altered in activity levels through the cell cycle. Second,
HSV might induce a cdk by a mechanism independent of
the cell cycle. Third, the inhibitors might not be specific
for cdk molecules. Identification of the cellular target(s)
of the cdk inhibitors that are essential for viral replication
will be necessary to distinguish between these possibil-
ities.
Potential roles of cell-cycle blocks in herpesvirus
replication
HSV can productively infect cells independently of the
stage of the cell cycle (Cohen et al., 1971; Cai and
Schaffer, 1991; Yeh and Knipe, unpublished results).
Therefore, it is not clear that it would be beneficial for the
virus to block the cell cycle, and indeed, the effect may
be secondary to some other effect(s) on the host cell.
However, several herpesviruses and herpesvirus gene
products have been shown to block the cell cycle in the
G1 phase, including Epstein–Barr virus (Cayrol and
Flemington, 1996a,b; Takese et al., 1996), human cyto-
megalovirus (Lu and Shenk, 1996; Dittmer and Mocarski,
1997), and bovine herpesvirus 1 (Schang et al., 1996).
hus, there may be some potential benefit of the cell-
ycle block for viral replication that is realized in vivo or
n other cell types. Obviously, inhibition of cellular DNA
ynthesis could provide metabolites or cellular compo-
ents that enhance viral DNA synthesis. Alternatively,
locking the host cell from entering S phase would pre-
ent the synthesis of histones, which could bind to viral
NA and decrease its transcription or replication.
On the other hand, the cell-cycle block may represent
host response to viral infection to protect the cell by
emoving it from the cell cycle until homeostasis is re-
tored. For example, G1 arrest has been associated withhe unfolded protein response resulting from a block in
yclin D1 translation (Brewer et al., 1999). By this model,the G1 block might not be advantageous for the virus but
rather for the host cell.
An understanding of the exact nature of this virus–host
cell interaction may come from further studies to define
the mechanism of viral-mediated inhibition of cyclin and
cdk expression and the viral gene products involved.
This work shows that accumulation of cyclins D1 and D3
is blocked by viral infection and that G1-specific forms of
cdk4 and cdk2 do not accumulate in infected cells. One
recently published study has shown that ICP0, overex-
pressed as the sole IE protein by a mutant HSV strain,
can induce cell-cycle blocks at both the G1/S and G2/M
boundaries (Hobbs and DeLuca, 1999). A second recent
study has shown that ICP0 expressed by transfection
inhibits cells in mitosis and at the G1/S-phase boundary
(Lomonte and Everett, 1999). It remains to be shown that
ICP0 is sufficient for cell-cycle arrest when expressed at
normal levels in the context of other IE proteins. Thus,
further studies are needed to identify the mechanism(s)
by which HSV infection leads to the block in expression
or modification of these molecules to gain further insight
into this virus–host cell interaction.
MATERIALS AND METHODS
Virus and cells. The HSV-1 strain KOS1.1 (Hughes and
Munyon, 1975) was originally obtained from M. Levine
(Univ. of Michigan). The HSV-2 strain 186 syn1-1 was
originally isolated as a nonsyncytial plaque (Spang et al.,
1983) from an HSV-2 strain 186 (Rawls et al., 1968) stock,
kindly provided by P. Schaffer (University of Pennsylva-
nia). CV-1 monkey kidney cells (American Type Culture
Collection, Rockville, MD) were grown as described in
Dulbecco’s modified minimal essential medium (Cell-
grow, Atlanta, GA), supplemented with 5% fetal bovine
serum (Gibco-BRL, Grand Island, NY) and 5% newborn
calf serum (Hyclone, Provo, UT) as described (Knipe and
Spang, 1982). Cells were growth-arrested by incubation
in 199 medium containing 1% calf serum for 24 h. Prior to
incubation in this medium, 48% of the cells were labeled
with BrdU and in S phase. After 24 h incubation in the 199
medium, less than 4% of the cells were labeled with
BrdU, indicating a cell-cycle arrest.
Antibodies. Immunoprecipitation of pRb was per-
formed with mouse anti-pRb monoclonal antibody
(PharMingen 14001A) at a dilution of 1:100. The antibod-
ies used for immunoblotting pRb, cyclins, and cdks were
as follows. Mouse anti-pRb monoclonal antibody
(PharMingen 14001A) was used at a 1:1000 or 1:2000
dilution. Mouse anti-cyclin D1 monoclonal antibody (San-
ta Cruz sc-8396) was used at a 1:500 dilution. Rat anti-
cyclin D2 monoclonal antibody (Santa Cruz sc-452) was
used at a 1:500 dilution. Mouse anti-cyclin D3 monoclo-
nal antibody (Santa Cruz sc-6283) was used at a 1:250 or
1:500 dilution. Rabbit anti-cyclin E polyclonal antibody
(Santa Cruz sc-198) was used at a 1:500 or 1:1000 dilu-
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333HSV INFECTION BLOCKS EVENTS IN G1 PHASE OF CELL CYCLEtion. Mouse anti-cdk2 monoclonal antibody (Santa Cruz
sc-6248) was used at a 1:500 or 1:1000 dilution. Rabbit
anti-cdk4 polyclonal antibody (Santa Cruz sc-260) was
used at a 1:1000 dilution. Mouse anti-cdk5 monoclonal
antibody (Santa Cruz sc-6247) was used at a 1:500 dilu-
tion. Rabbit anti-cdk6 polyclonal antibody (Santa Cruz
sc-177) was used at a 1:2000 dilution.
Phosphatase treatment. pRb immunocomplexes were
prepared as described earlier and resuspended in 60 ml
of a modified New England Biolabs (Beverly, MA) bacte-
rial phage l protein phosphatase buffer (50 mM Tris–
HCl, 5 mM DTT, 2 mM MnCl2, 100 mg/ml BSA, 1 mM
Leupeptin, 1 mM Pepstatin [Boehringer Mannheim, Indi-
anapolis, IN], 100 mM EDTA, and 200 mM PMSF). Five
hundred units of l protein phosphatase (New England
iolabs) were used to treat pRb present in the immuno-
omplex for 1 h at 30°C as reported previously (Vairo et
l., 1995). Phosphatase inhibitors, 10 mM sodium vana-
ate and 5 mM NaF, were also included in control reac-
ions to demonstrate the specificity of the phosphatase
eaction.
Phosphopeptide analysis. Mock-infected or HSV-1
OS1.1-infected CV-1 cells were labeled with 32P-phos-
phate. pRb was immunoprecipitated with mouse anti-
pRb monoclonal antibody, resolved by SDS–PAGE, and
excised from the gel. Phosphopeptide analysis was per-
formed as described previously (Xia et al., 1996). Briefly,
following trypsin digestion, the peptides were separated
in two dimensions on thin-layer plates by electrophoresis
and chromatography. The plates were exposed to X-ray
films with intensifying screens for autoradiography. Each
sample contained 500 Cerenkov cpm.
Immunoblot analysis. The harvested cell pellets, from
mock-infected and HSV-infected cells, were lysed in
SDS-containing sample buffer (62.5 mM Tris–HCl, pH 6.8;
2% [w/v] SDS; 20% glycerol; 0.5% [v/v] 2-mercaptoethanol;
0.1% [w/v] bromphenal blue). Proteins in the cell lysate
were resolved by SDS–PAGE (Knipe and Spang, 1982)
and electrophoretically transferred from the gels onto
nitrocellulose filters in a transfer apparatus according to
the procedures of the manufacturer (Bio-Rad). Expres-
sion of cyclins and cdks was monitored by probing the
blots with the primary antibodies described earlier, fol-
lowed by horseradish peroxidase-coupled secondary
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA)
and enhanced chemiluminescence (Amersham).
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